Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting NORD Summit, a Rare Disease Regulatory Wonderland By Juliet Moritz October 26, 2016 Tales from the Road – OBN Awards and ESMO Congress By Colin Hayward October 21, 2016 Consulting ‘Trailblazers’ needed to combat the agonizing scourge of addiction By Krista Armstrong October 20, 2016 Tales from the Road – Orphan Drugs Summit in Amsterdam By Juliet Moritz October 14, 2016 Consulting Developing & Negotiating a Study Budget By Daryl Fallon October 4, 2016 Consulting The Importance of Study Team Experience By Daryl Fallon August 31, 2016 Previous 1 …49 50 51 52 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today
